Skip to Main Content

Scheduled Maintenance: CDAS will be undergoing maintenance on Saturday, January 3^rd from 7:30 AM to 9:30 AM U.S. Eastern Standard Time for updates to the website. During this time you may experience intermittent downtime..

Browse Lab Results > 2006-0301

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Cancer Genetic Markers of Susceptibility (CGEMS): Contribution of Breast Cancer Cases and Controls from PLCO Cancer Screening Trial

Datasets

2006-0301 Primary

Site: Misc

Inclusion Criteria:

All I-Arm Females
Supplemental Questionnaire
No prior history of any cancer prior to SQX
No confirmed or reported cancers
No rare cancers
Subjects are dead
No oral contraceptive use (BQ)
No current hormone use (SQX and BQ)
Has Biochemical Consent
Has Serum and Plasma Available
Has Perfect Serum and Plasma Available
Has Perfect T4/5 Serum and Plasma Available
Has Serum and Plasma Available at the same study year (Eligible)
Randomly selected 30 (Selected)

Match Ratio: Not Applicable

Match Technique: Not Applicable

Analytes:

C-Peptide
Insulin-like Growth Factor 1
Insulin-like Growth Factor 2
Insulin-like Growth Factor Binding Protein 3
Leptin

Number of Controls: 30

Site: Misc

Inclusion Criteria:

All I-Arm Females
Supplemental Questionnaire
No prior history of any cancer prior to SQX
No confirmed or reported cancers
No rare cancers
Subjects are dead
No oral contraceptive use (BQ)
No current hormone use (SQX and BQ)
Has Biochemical Consent
Has Serum and Plasma Available
Has Perfect Serum and Plasma Available
Has Perfect T4/5 Serum and Plasma Available
Has Serum and Plasma Available at the same study year (Eligible)
Randomly selected 30 (Selected)

Match Ratio: Not Applicable

Match Technique: Not Applicable

Analytes:

C-Peptide
Insulin-like Growth Factor 1
Insulin-like Growth Factor 2
Insulin-like Growth Factor Binding Protein 3
Leptin

Number of Controls: 30